Session information

Luncheon Seminar

LS2-14

Eculizumab Application to PNH treatment: Risk of Meningococcal Infection that Hematologists should look out for

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.14 (Osaka International Convention Center, 8F 801-2)

Chair: Michihide Tokuhira (Saitama Medical Center, Saitama Medical University)

Sponsor: Alexion Pharma G.K.

[LS2-14] Eculizumab Application to PNH treatment: Risk of Meningococcal Infection that Hematologists should look out for

Junichi Nishimura¹, Tatsuya Kawaguchi² (1.Osaka University Graduate School of Medicine, 2.Faculty of Health Science, Kumamoto Health Science University)

▲